Aptissen is a company specialized in the research, development and commercialization of biopolymer-based medical devices. Aptissen SA stands for Advanced Polymer for TISSue ENgineering, which clearly gives a hint about the company’s skills. Aptissen’s founders have developed for the past 25 years the best quality injectable products to meet patient’s needs. Today we are active in the fields of Ophthalmology through surgical solutions for cataract and glaucoma, and of Orthopaedics, through innovative treatments for osteoarthritis.
Aptissen considers that the future of treatments for the synovial joints requires effective treatments administered in a single session, providing an improvement in mobility and a fast pain relief, as well as the regeneration of cartilage.
We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid that can be combined with other molecules. We plan to bring a clinically proven global approach, including oral or topical forms.
In Orthopaedics: Aptissen launched Synolis VA, the first Visco-Antalgic indicated for osteoarthritic synovial joints treatment. In Ophthalmology, Aptissen has developed HealaFlow the only injectable filtering spacer for Glaucoma surgery.